Comparison · NCT00189098-802e91c8
Sulfamethoxazole-trimethoprim vs Placebo: Number of Patients Who Underwent Ear Nose and Throat Surgery Between 12 Weeks and 1 Year Follow-up.
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Sulfamethoxazole-trimethoprim vs Placebo: Number of Patients Who Underwent Ear Nose and Throat Surgery Between 12 Weeks and 1 Year Follow-up. Trial comparisons, record NCT00189098-802e91c8. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00189098-802e91c8
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.295 | 0.182 | 0.442 | wilson | |
| Risk in group 2 | 0.239 | 0.139 | 0.379 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0563 | -0.124 | 0.234 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.24 | 0.621 | 2.46 | log | |
| Odds ratio, group 1 over group 2 | 1.33 | 0.523 | 3.41 | log | |
| Number needed to treat, for one more participant with the outcome on Sulfamethoxazole-trimethoprim than on Placebo | 17.8 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Sulfamethoxazole-trimethoprim | 13 | 44 | OG000 | |
| Group 2 | Placebo | 11 | 46 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Patients Who Underwent Ear Nose and Throat Surgery Between 12 Weeks and 1 Year Follow-up.
- Description
After 12 weeks follow-up irrespective of the presence or absence of otorrhea the study medication was discontinued. After the first 12 weeks local otorhinolaryngologists and paediatricians were free to manage symptoms of otorrhea according to their regular practice. Parents kept a diary between 12 weeks and 1 year follow-up where Ear Nose and Throat Surgery was noted. This outcome describes the number of patients who underwent Ear Nose and Throat Surgery between 12 weeks and 1 year follow-up.
- Time frame
- between 12 weeks and 1 year follow-up
- Population
Source ClinicalTrials.gov
Trial
- Title
- Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media
- NCT number
- NCT00189098
- Phases
- NA
- Conditions
- Chronic Otitis Media
- Interventions
- Sulfamethoxazole-trimethoprim, Placebo
- Lead sponsor
- UMC Utrecht
- Results first posted
- 2012-07-13
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00189098?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00189098-802e91c8